Cargando…
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis
INTRODUCTION: The purpose of this study was to evaluate the effects of L-4F, an apolipoprotein A-1 mimetic peptide, alone or with pravastatin, in apoE(-/-)Fas(-/-)C57BL/6 mice that spontaneously develop immunoglobulin G (IgG) autoantibodies, glomerulonephritis, osteopenia, and atherosclerotic lesion...
Autores principales: | Woo, Jennifer MP, Lin, Zhuofeng, Navab, Mohamad, Van Dyck, Casey, Trejo-Lopez, Yvette, Woo, Krystal MT, Li, Hongyun, Castellani, Lawrence W, Wang, Xuping, Iikuni, Noriko, Rullo, Ornella J, Wu, Hui, La Cava, Antonio, Fogelman, Alan M, Lusis, Aldons J, Tsao, Betty P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911877/ https://www.ncbi.nlm.nih.gov/pubmed/20482780 http://dx.doi.org/10.1186/ar3020 |
Ejemplares similares
-
Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2012) -
Leptin Enhances Availability of Apoptotic Cell-Derived Self-Antigen in Systemic Lupus Erythematosus
por: Amarilyo, Gil, et al.
Publicado: (2014) -
Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2013) -
Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes
por: Morgantini, Cecilia, et al.
Publicado: (2010) -
Vasculitis, Atherosclerosis, and Altered HDL Composition in Heme-Oxygenase-1-Knockout Mice
por: Ishikawa, Kazunobu, et al.
Publicado: (2012)